Site last updated: Sunday, November 22, 2026

Log In

Reset Password
Butler County's great daily newspaper

Courts drop verdicts in Merck suits

N.J., Texas void millions in damages involving Vioxx

NEWARK, N.J. — Appeals courts in New Jersey and Texas on Thursday scrapped verdicts against the drugmaker Merck & Co. stemming from some of the earliest trials involving its once popular painkiller Vioxx.

A Texas court reversed a $26 million verdict against the drug company stemming from the first trial. The court found no evidence that Robert Ernst suffered a fatal heart problem from a blood clot triggered by Vioxx. He had been taking the now-withdrawn drug for eight months before being stricken in May 2001.

His widow had won a $253 million verdict against New Jersey-based Merck in 2005, but Texas punitive damage caps later cut that to about $26 million.

Also Thursday, a New Jersey appeals court voided $9 million of the $13.9 million awarded to John McDarby in 2006 by a jury in Atlantic City. The panel vacated the punitive damage award because it found that the punitive damages requirement in New Jersey's Product Liability Act was pre-empted by the federal Food Drug and Cosmetic Act.

McDarby survived his 2004 heart attack, but died last fall from complications of his heart problems, his lawyer said.

The panel affirmed $4.5 million in compensatory damages to McDarby, awarded when the New Jersey jury found Merck failed to warn of Vioxx's cardiac risks.

More in Business

Subscribe to our Daily Newsletter

* indicates required
TODAY'S PHOTOS